Tisch MS News

This week, your Tisch MSRCNY researchers are at the Society for Neuroscience (SfN) in San Diego, CA presenting their research from our lab. Stay tuned for an article to learn more about their trip and the abstracts that they presented in the Fall Issue of the Healing MS Newsletter -- hitting your...

November 5, 2018

More

Over 1,000 people have already registered for the 21st Annual Tisch MS Research Center Patient Symposium. We have a great day planned. Seating is limited and registration is required. Reserve your spot today! https://tischmsrcnysymposium2018.eventbrite.com

September 21, 2018

More

In observance of Independence Day, the Tisch MS Research Center of New York will close today at 2:00pm and remain closed through the 4th. We wish our patients, friends and supporters a safe, happy and healthy 4th of July!

July 3, 2018

More

Your Tisch MS Researchers will be attending this year's 2018 AAN conference in Los Angeles California on April 21st-27th. Stay tuned for planned poster board presentations out of the Tisch MSRCNY lab! For more information on this year's conference, you can visit their website .

April 3, 2018

More

Tisch MSRCNY wishes everyone observing Passover, a holiday filled with peace, prosperity and good health. Chag Sameach!

March 30, 2018

More

To our staff, friends & supporters celebrating Good Friday and Easter this weekend, we wish you a happy and healthy holiday weekend!

March 30, 2018

More

Due to the impending storm and weather conditions, the Tisch MS Research Center of New York will be closed on Wednesday, March 21, 2018. Please stay safe and warm!

March 20, 2018

More

written by Dr. Armistead Williams A new report from an annual meeting of hematologists showed positive results for using hematopoietic stem cell transplantation (AHSCT) to treat relapsing-remitting MS. The results reflect what we already know about AHSCT: that it is highly effective in relapsing-...

March 19, 2018

More

For Immediate Release RESEARCHERS SHOW STEM CELL THERAPY MAY REVERSE DISABILITY IN MULTIPLE SCLEROSIS New York, NY – February 6, 2018 – Researchers at Tisch MS Research Center of New York (Tisch MSRCNY) have shown a stem cell-based treatment may reverse disability in progressive multiple sclerosis...

February 6, 2018

More

This study, recently published in the journal JAMA Neurology, examined the use of Rituximab as a first-line MS treatment in Sweden. Rituximab is already extensively used in Sweden but this study showed the improved efficacy and safety of using Rituximab as a first MS treatment as compared to other...

January 24, 2018

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.